Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis
2018-001216-29Phase 2Completed
- Sponsor
- PRCL Research
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of PRCL-02 in plaque psoriasis, sponsored by PRCL Research. Primary endpoint: PASI 75 response at Week 12. Started Aug 2018; status: completed.
02
Drugs
PRCL-02
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2018-001216-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001216-29.